This is reflected clinically by a 23-fold increase in circulating heparan sulfate among patients with sepsis-induced lung injury compared to healthy controls (35) and higher syndecan-1 levels, another marker of glycocalyx degradation, in septic shock patients with acute respiratory distress syndrome (ARDS) compared with those without it (36). The gene discussed is SDC1; the disease is acute respiratory distress syndrome.